HBM7575
/ Harbour BioMed, Sichuan Kelun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 09, 2026
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis
(PRNewswire)
New trial • Atopic Dermatitis
1 to 1
Of
1
Go to page
1